Overview

Update
IPO / Stock
Went Public on Apr 22, 2010 / NASDAQ:ALIM
Total Equity Funding
$93.55M in 4 Rounds from 5 Investors
Headquarters:
Alpharetta, GA
Description:
Alimera Sciences is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals.
Founders:
,
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.alimerasciences.com
Social:

Company Details

Update
Founded:
2003
Contact:
678-990-5740
Employees:
51 - 100 | 7 in Crunchbase

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

Funding Rounds (8) - $232.55M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2016$26.5M / Post Ipo Equity0
Apr, 2014$35M / Post Ipo Debt0
Jan, 2014$37.5M / Post Ipo Equity0
Oct, 2012$40M / Post Ipo Equity0
Oct, 2009$5M / Series C5
Mar, 2008$30M / Series C0
Nov, 2005$31.8M / Series B5
Jul, 2004$26.75M / Series A4

Current Team (7)

Update

Products (1)

Update
  • Iluvien was added to CrunchBase in 2009

Offices/Locations (1)

Update
  • Headquarters

    6120 Windward Parkway

    Suite 290

    Alpharetta, GA 30005

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos